术后T1a与T1b肾细胞癌的肺部监测方案是否应分开?多中心数据库分析
平均随访45和43个月,T1a与T1b分别平均行2.96和2.99次胸片,3年内胸片监测在T1a检出0例、T1b检出2例无症状肺转移。结论提示术后肺部监测应保留给T1b,T1a可能无需常规胸片监测。
要点
- T1a患者3年内胸片监测未检出无症状肺转移,T1b检出2例。
- 胸片监测假阳性导致不必要辐射和潜在活检,T1a获益低。
- 部分切除与根治切除的肺转移发生率无差异(P = .62)。
核心结论
- 术后肺部监测应保留给T1b肾细胞癌患者,T1a可能无需常规胸片监测。
主要发现
- T1a组384例,平均随访45个月,平均胸片2.96次;T1b组184例,平均随访43个月,平均胸片2.99次。
- T1a和T1b分别有5.7%(22例)和5.4%(10例)发现性质待定病灶,经胸部CT和活检确诊肺转移分别为0.01%(2例)和1.1%(2例)。
- 3年胸片监测期间,T1a组检出无症状肺转移0例,T1b组检出2例。
- 肺转移患者均无高危病理特征。
- 肾部分切除术与根治性切除术的肺转移发生率无差异(3/290 vs 1/278,P = .62)。
临床怎么用
- 对T1b肾细胞癌术后患者可考虑继续胸部X线监测,T1a患者可能无需常规胸片监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the incidence of pulmonary metastases (PM) and the utility of the surveillance chest radiography (CXR) in detecting PM after curative treatment to better define surveillance recommendations for T1a and T1b renal cell carcinoma. MATERIALS AND METHODS: A retrospective review of a multi-institutional database was performed to include patients with renal masses treated with partial nephrectomy or radical nephrectomy. Patients were excluded for ≥T2 disease, benign pathology, and metastases. The primary outcome was the incidence of asymptomatic pulmonary lesion concerning for PM detected by CXR within 3 years. RESULTS: Five hundred sixty-eight patients met criteria of which 384 had T1a and 184 had T1b at a mean follow-up of 45 and 43 months, respectively. Patients averaged 2.96 and 2.99 CXRs for T1a and T1b with 46.8% having surveillance beyond 3 years. Indeterminate lesions were found in 5.7% (22) of T1a and 5.4% (10) in T1b of which 0.01% (2) and 1.1% (2) were confirmed PM by chest computed tomography and biopsy. Three-year CXR surveillance period detected asymptomatic PM in zero and two patients for T1a and T1b, respectively. High risk pathological features were not present in patients with PM. There was no difference in the incidence PM for patients undergoing partial nephrectomy (3/290) or radical nephrectomy (1/278) (P = .62). CONCLUSION: Our review suggests that post-treatment pulmonary surveillance should be reserved for T1b and may not be required for T1a given the low yield and false positives of CXR leading to unnecessary radiation and potential biopsies.
引用
- Chow AK, Kahan AN, Hwang T, et al. Should We Separate the Pulmonary Surveillance Protocol for Postsurgical T1a and T1b Renal Cell Carcinoma? A Multicenter Database Analysis. Urology. 2018. PMID: 30205104. doi:10.1016/j.urology.2018.08.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。